Bromocriptine-induced rotation: characterization using a striatal efferent lesion in the mouse

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Bromocriptine (BRC) is a dopamine receptor agonist with complex behavioral effects.
• Understanding the precise neural pathways mediating BRC's actions is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the role of specific dopaminergic pathways in mediating bromocriptine (BRC)-induced behaviors.
• To elucidate the mechanism of action of BRC, particularly concerning D-1 and D-2 receptor interactions.

Main Methods:

• Utilized two distinct lesion techniques in mice: unilateral 6-hydroxydopamine (6-OHDA) and striatonigral/striatoentopeduncular lesions.
• Administered BRC and observed behavioral responses, including rotation and general activation.
• Investigated the effect of alpha-methyl-para-tyrosine (AMPT) on BRC-induced behaviors to assess the role of presynaptic dopamine.

Main Results:

• Unilateral 6-OHDA lesions led to BRC-induced contralateral rotation, blocked by AMPT.
• Striatonigral/striatoentopeduncular lesions abolished BRC-induced rotation but allowed for general activation, also inhibited by AMPT.
• BRC-induced rotation requires dopaminergic asymmetry and intact presynaptic dopamine.

Conclusions:

• BRC-induced rotation is dependent on the presence of dopaminergic asymmetry, such as that created by 6-OHDA lesions.
• The behavioral effects of BRC, a D-2 agonist, appear to involve coactivation of D-1 receptors by endogenous dopamine.
• BRC's actions are mediated by neural pathways distinct from the striatonigral and striatoentopeduncular pathways.